Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
MasterCard
MA
JP Stock MarketDetailed Quotes
4556 KAINOS Laboratories
- 1231
- +4+0.33%
20min DelayMarket Closed May 2 15:30 JST
5.61BMarket Cap8.08P/E (Static)
1239High1211Low1.20KVolume1239Open1227Pre Close1.47MTurnover132152wk High0.07%Turnover Ratio4.56MShares103552wk Low146.14EPS TTM2.02BFloat Cap2047Historical High8.08P/E (Static)1.64MShs Float99Historical Low152.26EPS LYR2.28%Amplitude32.00Dividend TTM0.80P/B100Lot Size2.60%Div YieldTTM
KAINOS Laboratories News
KAINOS Laboratories: Notice regarding revisions to dividend forecasts (50th anniversary dividend)
KAINOS Laboratories: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Half Year Report - Term 50 (2024/04/01 - 2025/03/31)
KAINOS Laboratories: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
KAINOS Laboratories: March 2025 First Quarter Fiscal Results Announcement [Japanese Standards] (Non-consolidated)
KAINOS Laboratories: Interim report
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Securities report - 49th period (April 1, 2023 - March 31, 2024)
KAINOS LABORATORIES: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Kainos: Notice Concerning Revision of Dividend Forecast for the Fiscal Year Ending March 2024 (49th Term)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Quarterly Report - 49th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
KAINOS Laboratories: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Quarterly Report - 49th Second Quarter (2023/07/01 - 2023/09/30)
KAINOS Laboratories: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (unconsolidated)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Quarterly Report - 49th Quarter 1 (2023/04/01 - 2023/06/30)
KAINOS Laboratories: Summary of Financial Results for the 1st Quarter Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts